COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 202 filers reported holding COHERUS BIOSCIENCES INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,931 | +26.7% | 5,864 | +44.7% | 0.00% | 0.0% |
| Q2 2023 | $17,306 | -48.6% | 4,053 | -4.6% | 0.00% | -50.0% |
| Q4 2022 | $33,652 | -17.6% | 4,249 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $40,833 | +32.7% | 4,249 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $30,763 | -43.9% | 4,249 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $54,855 | -80.7% | 4,249 | -76.1% | 0.00% | -50.0% |
| Q4 2021 | $284,295 | -0.7% | 17,813 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $286,255 | +23.3% | 17,813 | +12.1% | 0.00% | +33.3% |
| Q1 2021 | $232,197 | -24.9% | 15,893 | -10.7% | 0.00% | -40.0% |
| Q4 2020 | $309,173 | -14.7% | 17,789 | -12.3% | 0.01% | -16.7% |
| Q2 2020 | $362,451 | -13.8% | 20,294 | -2.2% | 0.01% | -14.3% |
| Q3 2019 | $420,294 | +11.4% | 20,745 | +21.5% | 0.01% | +16.7% |
| Q2 2019 | $377,269 | +62.0% | 17,071 | 0.0% | 0.01% | +50.0% |
| Q1 2019 | $232,848 | +50.7% | 17,071 | 0.0% | 0.00% | +33.3% |
| Q4 2018 | $154,493 | -54.2% | 17,071 | +1.5% | 0.00% | +50.0% |
| Q3 2015 | $337,000 | – | 16,813 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 200,000 | $1,448,000 | 1.54% |
| Tri Locum Partners LP | 376,486 | $2,726,000 | 1.12% |
| Perceptive Advisors | 3,645,471 | $26,393,000 | 0.83% |
| TANG CAPITAL MANAGEMENT LLC | 750,000 | $5,430,000 | 0.82% |
| Bridge City Capital, LLC | 162,146 | $1,174,000 | 0.62% |
| Knott David M Jr | 186,134 | $1,348,000 | 0.57% |
| Aristotle Capital Boston, LLC | 2,322,168 | $16,812,000 | 0.50% |
| Phocas Financial Corp. | 316,455 | $2,291,000 | 0.34% |
| Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $22,644,000 | 0.30% |
| Temasek Holdings (Private) Ltd | 7,381,116 | $53,439,280 | 0.29% |